focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

Share Price Information for Ovoca Bio (OVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.725
Bid: 0.65
Ask: 0.80
Change: 0.00 (0.00%)
Spread: 0.15 (23.077%)
Open: 0.725
High: 0.725
Low: 0.725
Prev. Close: 0.725
OVB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Goltsovoye Public Hearings

19 Jun 2008 10:38

RNS Number : 0762X
Ovoca Gold PLC
19 June 2008
 



Ovoca Gold plc ("Ovoca" or the "Company")

Goltsovoye Public Hearings

Ovoca Gold Plc., London (OVG.L), Dublin (OVX.IR), Frankfurt (OVX.GR) ("the Company") is pleased to announce that public hearings to review environmental aspects of the Goltsovoye mine and processing complex were successfully conducted in Omsukchan, the administrative centre of the Magadan Oblast. No substantive objections from the public were raised during the hearings and this was recorded in a memorandum of understanding between, amongst others, the company, a number of local interest groups and local government authorities. Interests of the public were represented by local and regional environmental organizations and local interest groups.

The public hearing, a requirement under Russian legislation, concludes preparation of the Goltsovoye development plan. The development plan will be submitted to Federal authorities for final approval.

Leonid Skoptsov, the Ovoca CEO, comments:

"I am pleased to note that the policy of openness and transparency implemented by the Company is showing encouraging results. The public has responded positively to the efforts made by the Company to prevent the possibility of damage to the region's environment. The large number of participants at the public hearings indicates that not only Ovoca, but also the local residents eagerly await the completion of the project design stage and the transition to full-scale construction. Which will lead to new jobs and a powerful impetus to further development of the region's economy."

Mr Danesh Varma CFO, Company Secretary
+44 (0)20 7937 8151 danesh.varma@ovocagold.com
Mr Leonid Skoptsov CEO

+7 495 648 26 46 leonid.skoptsov@ovocagold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFLMLTMMJBMIP
Date   Source Headline
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.